Markets:

Overview

News

Currencies

International

Treasuries

Exact Sciences Corporation - Common Stock (NQ:EXAS)

101.74 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Dec 15, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Exact Sciences Corporation - Common Stock

< Previous 1 2

...

9 10 11 12 13 14 15 16 17

...

21 22 Next >

This Analyst With 83% Accuracy Rate Sees Around 25% Upside In Amazon.com - Here Are 5 Stock Picks For Last Week From Wall Street's Most Accurate Analysts ↗

August 07, 2023

U.S. stocks closed lower on Friday, as investors digested the recent jobs data. The S&P 500 fell for a fourth consecutive session, also recording its worst week since March. The Dow fell 1.1%, while...

Via Benzinga

Market Rally Under Pressure As Yields Soar; Amazon, ELF, Caterpillar Are Earnings Winners: Weekly Review ↗

August 04, 2023

Amazon, ELF and CAT were earnings winners, but there were big losers too.

Via Investor's Business Daily

Why Exact Sciences Stock Slumped Wednesday ↗

August 02, 2023

The biotech's Q2 numbers were impressive overall, but Wall Street apparently wasn't satisfied.

Via The Motley Fool

Exact Sciences (EXAS) Q2 2023 Earnings Call Transcript ↗

August 01, 2023

EXAS earnings call for the period ending June 30, 2023.

Via The Motley Fool

Earnings Preview For Exact Sciences ↗

July 31, 2023

Via Benzinga

2 Revolutionary Stocks to Buy and Hold for 10 Years ↗

July 22, 2023

Breaking new ground can be highly lucrative.

Via The Motley Fool

Why Shares of Exact Sciences Corporation Are Down This Week ↗

August 03, 2023

The company released second-quarter earnings that were improved, but investors were unimpressed.

Via The Motley Fool

Exact Sciences Q2 Earnings Surpass Expectation, But Analyst Says Stock Has Limited Growth ↗

August 02, 2023

Exact Sciences Corp (NASDAQ: EXAS) reported Q2 revenue of $622 million, an increase of 19%, and $617 million of core revenue, an increase of 24%, beating the

Via Benzinga

Why Exact Sciences Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

August 02, 2023

Gainers WaveDancer, Inc. (NASDAQ: WAVD) shares climbed 86% to $0.5505. Tellenger, a subsidiary of Wavedancer, Inc., won a seven-year U.S. government contract.

Via Benzinga

Expert Ratings for Exact Sciences ↗

July 21, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 2, 2023 ↗

August 02, 2023

Via Benzinga

Exact Sciences, A Cathie Wood Darling, Just Reported A Sixth Big Sales Quarter ↗

August 01, 2023

The company is a leader in using diagnostics to screen for early cancer cases.

Via Investor's Business Daily

Accenture, Hewlett Packard Enterprise And 2 Other Stocks Insiders Are Selling ↗

July 31, 2023

The Nasdaq 100 closed higher on Friday. Investors, meanwhile, focused on some notable insider trades.

Via Benzinga

Cathie Wood's Ark Invest Continues To Sell Shares Of Warren Buffett-Backed BYD — Coinbase Holdings Trimmed As Well ↗

July 26, 2023

Via Benzinga

Analyst Ratings for Exact Sciences ↗

June 23, 2023

Via Benzinga

Canaccord Genuity Maintains Buy Rating for Exact Sciences: Here's What You Need To Know ↗

June 23, 2023

Via Benzinga

Cathie Wood's Ark Invest Makes Major Moves In This Warren Buffett-Backed EV Company, Moderna ↗

July 24, 2023

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

July 24, 2023

Via Benzinga

3 Growth Stocks Every Investor Should Know About Now ↗

July 23, 2023

While a countless number of ideas flood the capital markets, these must-know growth stocks should be on your radar.

Via InvestorPlace

2 Cathie Wood Growth Stocks That Could Make You Richer ↗

July 18, 2023

These two biotechs could be winning plays for aggressive investors.

Via The Motley Fool

Amicus Therapeutics Stock Sees Improving Market Leadership; Earns 81 RS Rating ↗

July 17, 2023

On Monday, Amicus Therapeutics stock got an upgrade to its Relative Strength (RS) Rating, to 81, up from 74 a day earlier.

Via Investor's Business Daily

ARKK: The Pros and Cons Of Buying Into Cathie's Best-Known ETF

July 13, 2023

If you're a believer in the progress of science and technology and feel strongly that our best days are still ahead, then a slice of ARKK could be tempting.

Via MarketBeat

Topics ETFs Economy

ETF Returns: Mid-Cap Winners And Losers ↗

June 28, 2023

We performed a screening of mid-cap ETFs - defined as having Assets Under Management (AUM) between $2 billion and $10 billion - to determine what funds had the largest positive and negative returns on...

Via Benzinga

Analysts Think This Soaring Cathie Wood Stock Has Peaked. Are They Right? ↗

June 28, 2023

Is it a matter of time before Exact Sciences stock starts giving back some of its impressive gains this year?

Via The Motley Fool

Cathie Wood's Ark Outshines S&P 500, Nasdaq In H1: Here Are The Major Trades It Made ↗

June 28, 2023

Via Benzinga

This Big Cathie Wood Stock Is Outperforming Even Tesla ↗

June 26, 2023

DraftKings is the strongest performer among Ark Invest's major holdings.

Via Investor's Business Daily

Cologuard's Improved Performance to Accelerate Growth, Analyst Raises Expectations ↗

June 23, 2023

Tuesday, Exact Sciences Corp (NASDAQ: EXAS) announced topline results from the pivotal BLUE-C study, showing that next-generation

Via Benzinga

Stock Market Pulls Back After Several Weeks Of Gains: Weekly Review ↗

June 23, 2023

But the major indexes and leading stocks generally showed healthy action.

Via Investor's Business Daily

Analysts Bullish On Exact Sciences' Advanced Cancer Screening

June 23, 2023

Exact Sciences sees a bump in stock price amid rising revenue and study results that show advancements to its flagship Cologuard colorectal screening product.

Via MarketBeat

Exact Sciences Set To Dominate Emerging Precision Oncology Market: Analyst Applauds $18B Potential Market ↗

June 22, 2023

Benchmark analyst Bruce D.

Via Benzinga

< Previous 1 2

...

9 10 11 12 13 14 15 16 17

...

21 22 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Exact Sciences Corporation - Common Stock (NQ:EXAS)

All News about Exact Sciences Corporation - Common Stock

Starting at $3.75/week.

Subscribe Today